通信電纜 網絡設備 無線通信 云計算|大數據 顯示設備 存儲設備 網絡輔助設備 信號傳輸處理 多媒體設備 廣播系統 智慧城市管理系統 其它智慧基建產品
北京方程嘉鴻科技有限公司
北京方程嘉鴻科技有限公司
北京方程生物公司經營銷售T細胞活化連接蛋白（LAT）ELISA試劑盒，可以提供免費代測，送檢贈京東卡活動正在進行中，詳情咨詢銷售人員
AGRP
試劑盒名稱:T細胞活化連接蛋白(LAT)ELISA試劑盒
英文名：Human Agouti Related Protein,AGRP
品牌:BIOFINE
種屬:大鼠ELISA試劑盒
檢測波長:450nm
所需樣本體積: 50-100ul
適用范圍:僅供科研
保存及有效期:2-8℃，六個月，-20℃一年
檢測目的:用于測定血清，血漿及相關液體T細胞活化連接蛋白(LAT)含量。適合檢測包括血清、血漿、尿液、胸腹水、灌洗液、腦脊液、細胞培養上清、組織勻漿等標本。
注意事項：1. 當混合蛋白溶液時應盡量輕緩，避免起泡。2. 洗滌過程非常重要，不充分的洗滌易造成假陽性。3. 一次加樣時間控制在5分鐘內，如標本數量多，*使用排槍加樣。4. 請每次測定的同時做標準曲線，做復孔。5. 如標本中待測物質含量過高，請先稀釋后再測定，計算時請zui后乘以稀釋倍數。6. 在配制標準品、檢測溶液工作液時，請以相應的稀釋液配制，不能混淆。7. 底物請避光保存。8. 不要用其它生產廠家的試劑替換試劑盒中的試劑。
T細胞活化連接蛋白(LAT)contains the standard concentration of analyte will be prepared. Unknowns that generate a signal that is stronger than the known sample are "positive." Those that generate weaker signal are "negative." Doctor Dennis E Bidwell and Alister Voller created the test. History Before the development of the ELISA, the only option for conducting an immunoassay was radioimmunoassay, a technique using radioactively-labeled antigens or antibodies. In radioimmunoassay, the radioactivity provides the signal, which indicates whether a specific antigen or antibody is present in the sample. Radioimmunoassay was first described in a paper by Rosalyn Sussman Yalow and Solomon Berson published in 1960.[5] Because radioactivity poses a potential health threat, a safer alternative was sought. A suitable alternative to radioimmunoassay would substitute a non-radioactive signal in place of the radioactive signal. When enzymes (such as peroxidase) react with appropriate substrates (such as ABTS or 3,3’,5,5’-Tetramethylbenzidine), a change in color occurs, which is used as a signal. However, the signal has to be associated with the presence of antibody or antigen, which is why the enzyme has to be linked to an appropriate antibody. This linking process was independently developed by Stratis Avrameas and G.B. Pierce.[6] Since it is necessary to remove any unbound antibody or antigen by washing, the antibody or antigen has to be fixed to the surface of the container; i.e., the immunosorbent has to be prepared. A technique to accomplish this was published by Wide and Jerker Porath in 1966.[7] In 1971, Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in The Netherlands independently published papers that synthesized this knowledge into methods to perform EIA/ELISA.[8][9]
T細胞活化連接蛋白(LAT)
16α羥基雌酮1(16-α OHE-1)
破傷風抗體(Tetanus Ab)
載脂蛋白A5(apo-A5)
*羥化酶(TH)
絲裂原活化蛋白激酶激酶6(MKK6)
白介素4(IL-4)
抗核抗體(ANA)
preptin
骨成型蛋白受體1A(BMPR-1A)
*(Cyt-C)
高速泳動蛋白17(HMG-17)
硒蛋白1(SEP1)
您感興趣的產品PRODUCTS YOU ARE INTERESTED IN
智慧城市網 設計制作，未經允許翻錄必究 .? ? ?
請輸入賬號
請輸入密碼
請輸驗證碼
